ResearcherChristian-Albrechts-Universität zu KielActive in the last 2 years
Annika Bräuer
Matched on ORCID iD 0009-0001-1567-1670; OpenAlex author ID A5073810659. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2026: 3 papers
Papers 3
- Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer. Co-author DOI 10.1016/j.biopha.2026.119257↗
- Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-026-01663-z↗
- L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the complex tumor stroma First author DOI 10.64898/2026.08.10.743835↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rüdiger Braun · 3 shared papers, 2026 · strength 0.69
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Christoph Röcken · 3 shared papers, 2026 · strength 0.69
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Anna Maxi Wandmacher · 3 shared papers, 2026 · strength 0.69
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Susanne Sebens · 3 shared papers, 2026 · strength 0.69
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Daniela Wesch · 2 shared papers, 2026 · strength 0.47
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Anne‐Sophie Mehdorn · 2 shared papers, 2026 · strength 0.47
- Paper Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic… DOI 10.1016/j.biopha.2026.119257↗
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Benjamin Heckelmann · 2 shared papers, 2026 · strength 0.46
- Paper L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the… DOI 10.64898/2026.08.10.743835↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Rainer Lothar Heuchel · 1 shared paper, 2026 · strength 0.24
- Jan-Paul Gundlach · 1 shared paper, 2026 · strength 0.24
- Tina Daunke · 1 shared paper, 2026 · strength 0.23
- Silje Beckinger · 1 shared paper, 2026 · strength 0.23
- Tobias Keck · 1 shared paper, 2026 · strength 0.22
- Louisa Bolm · 1 shared paper, 2026 · strength 0.22
- Corinna Ulrike Keber · 1 shared paper, 2026 · strength 0.22
- Steffen Deichmann · 1 shared paper, 2026 · strength 0.22
- Kim C. Honselmann · 1 shared paper, 2026 · strength 0.22
- Jens Uwe Marquardt · 1 shared paper, 2026 · strength 0.22
- Ulrich Friedrich Wellner · 1 shared paper, 2026 · strength 0.22
- Benedikt Färber · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.